AstraZeneca PLC (NASDAQ:AZN)

53.11
Delayed Data
As of 4:00pm ET
 +0.84 / +1.61%
Today’s Change
46.48
Today|||52-Week Range
64.94
+6.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$133.2B

Company Description

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Contact Information

AstraZeneca Plc
Cambridge Biomedical Campus
Cambridge Cambridgeshire CB2 0AA
P:442037495000
Investor Relations:
442037495712

Employees

Shareholders

Mutual fund holders8.99%
Other institutional6.40%
Individual stakeholders--

Top Executives

Pascal SoriotChief Executive Officer & Executive Director
Pam P. ChengExecutive VP-Operations & Information Technology
Marc Pierre Jean DunoyerChief Financial Officer & Executive Director
Menelas N. PangalosEVP-Biopharmaceuticals Research & Development
Henry D. CremisiMedical Director